Laron syndrome GH insensitivity is a dubious disease in the field of genetic metabolism, with complex clinical outcomes that often involve multi-system fatigue. Early identification and standardised clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory checks and pathological evaluations.
The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnoses and treatment regimens. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustments according to the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of Laron syndrome GH-insensitivity. The platform serves a team of domestic and foreign experts in the field of genetic metabolism linked to the China International Medical Service System, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.